Preparation of modified chitosan - amino acid nanoparticles

Abstract

Chitosan nanoparticles have increased more consideration as medication transporters in view of their better solidness, basic arrangement and flexible courses of organization. Common and engineered degradable polymers are perfect bearer particles. The medication can be joined into the polymer where the discharge relies on upon either their progressive dissemination from the polymeric lattice, the disintegration of the network, or discharge from the surface of the grid. Chitosan is a remarkable characteristic polymer for the conveyance of helpful specialists since it is non-toxic, biocompatible, biodegradable, and has mucoadhesive properties. To be named ”chitosan,” the deacety-lated chitin ought to contain no less than 60% of D-glucosamine deposits. By fusing drug particles in chitosan nanoparticles, the leeway can be diminished, and the flow half-existence of the medication augmented. The results of this study show that there is a good relationship between the weight of carrier (chi-tosan) and weight of drug (silymarin), it gives the best total releasing percent at the weight percent 10:1, while the best-encapsulating percent and loading capacity percent occurred at the weight percent of 10:2, and there is no effect on continuous increase in the weight of the carrier. With respect to the dialysis period, it seemed that there is no evidence of increasing the dialysis time more than 12 hours because of the stability of the total releasing percent and loading capacity percent.